Literature DB >> 3288296

Genetically engineered antibody molecules: new tools for cancer therapy.

S L Morrison1, L A Wims, V T Oi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3288296     DOI: 10.3109/07357908809077046

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  2 in total

1.  Specific enzyme-linked immunosorbent assays for quantitation of antibody-cytokine fusion proteins.

Authors:  J Gan; K Kendra; M Ricci; J A Hank; S D Gillies; P M Sondel
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  The 4C5 cell-impermeable anti-HSP90 antibody with anti-cancer activity, is composed of a single light chain dimer.

Authors:  Katerina Sidera; Avraam El Hamidieh; Avgi Mamalaki; Evangelia Patsavoudi
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.